Mitochondrial DNA depletion in single fibers in a patient with novel TK2 mutations

被引:11
|
作者
Roos, S. [1 ]
Lindgren, U. [1 ]
Ehrstedt, C. [2 ]
Moslemi, A. R. [1 ]
Oldfors, A. [1 ]
机构
[1] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Pathol, SE-41345 Gothenburg, Sweden
[2] Uppsala Univ, Childrens Hosp, Dept Womens & Childrens Hlth, Uppsala, Sweden
基金
瑞典研究理事会;
关键词
Mitochondrial DNA depletion syndrome; Myopathy; Thymidine kinase 2; TK2; Mitochondrial myopathy; MTDNA DEPLETION; THYMIDINE KINASE; COENZYME Q(10); GENE; DELETIONS; MYOPATHY; MUSCLE; DEFECTS;
D O I
10.1016/j.nmd.2014.05.009
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The mitochondrial DNA (mtDNA) depletion syndrome is a genetically heterogeneous group of diseases caused by nuclear gene mutations and secondary reduction in mtDNA copy number. We describe a patient with progressive muscle weakness and increased creatine kinase and lactate levels. Muscle weakness was first noted at age 1.5 years and he died of respiratory failure and bronchopneumonia at age 3.5 years. The muscle biopsy showed dystrophic features with ragged red fibers and numerous cytochrome c oxidase (COX)-negative fibers. qPCR analysis demonstrated depletion of mtDNA and sequence analysis of the mitochondrial thymidine kinase 2 (TK2) gene revealed two novel heterozygous variants, c.332C > T, p.(T111I) and c.156 + 5G > C. Quantitative analysis of mtDNA in single muscle fibers demonstrated that COX-deficient fibers showed more pronounced depletion of mtDNA when compared with fibers with residual COX activity (P < 0.01, n = 25). There was no evidence of manifestations from other organs than skeletal muscle although there was an apparent reduction of mtDNA copy number also in liver. The patient showed a pronounced, albeit transient, improvement in muscle strength after onset of treatment with coenzyme Q10, asparaginase, and increased energy intake, suggesting that nutritional modulation may be a therapeutic option in myopathic mtDNA depletion syndrome. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:713 / 720
页数:8
相关论文
共 50 条
  • [41] Tracking cellular stress with labeled FMAU reflects changes in mitochondrial TK2
    Tehrani, Omid S.
    Douglas, Kirk A.
    Lawhorn-Crews, Jawana M.
    Shields, Anthony F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 (08) : 1480 - 1488
  • [42] Mitochondrial DNA depletion and dGK gene mutations
    Salviati, L
    Sacconi, S
    Mancuso, M
    Otaegui, D
    Camaño, P
    Marina, A
    Rabinowitz, S
    Shiffman, R
    Thompson, K
    Wilson, CM
    Feigenbaum, A
    Naini, AB
    Hirano, M
    Bonilla, E
    DiMauro, S
    Vu, TH
    ANNALS OF NEUROLOGY, 2002, 52 (03) : 311 - 317
  • [43] Mitochondrial DNA mutations and depletion in pediatric medicine
    Spinazzola, A.
    SEMINARS IN FETAL & NEONATAL MEDICINE, 2011, 16 (04): : 190 - 196
  • [44] Mitochondrial deoxyguanosine kinase mutations and mitochondrial DNA depletion syndrome
    Wang, LY
    Eriksson, S
    FEBS LETTERS, 2003, 554 (03) : 319 - 322
  • [45] D-loop mutations in mitochondrial DNA:: link with mitochondrial DNA depletion?
    Barthélémy, C
    de Baulny, HO
    Lombès, A
    HUMAN GENETICS, 2002, 110 (05) : 479 - 487
  • [46] D-loop mutations in mitochondrial DNA: link with mitochondrial DNA depletion?
    Cyrille Barthélémy
    Hélène de Baulny
    Anne Lombès
    Human Genetics, 2002, 110 : 479 - 487
  • [47] Muscle magnetic resonance imaging involvement in mitochondrial myopathy due to TK2 deficiency
    Sanchez-Montanez, A.
    Martinez-Saez, E.
    Garcia de la Banda, M. Gomez
    Julia, N.
    Quijano-Roy, S.
    Olive, M.
    Garcia-Arumi, E.
    Gratacos, M.
    Buendia, J.
    Delgado, I.
    Vazquez, E.
    Roig, M.
    Munell, F.
    NEUROMUSCULAR DISORDERS, 2016, 26 : S178 - S179
  • [48] Age-Associated Mitochondrial Dysfunction and Cardiac Hypertrophy in Cardiac Targeted Transgenic Models of Mutations in TK2 or Pol γ with NRTI Treatment
    Kohler, James J.
    Hosseini, Seyed
    Cucoranu, Ioan
    Hoying, Amy
    Green, Elgin
    Fields, Earl
    Johnson, David
    Russ, Rodney
    Lewis, William
    CIRCULATION RESEARCH, 2008, 103 (05) : E67 - E67
  • [49] siRNA targeting of mitochondrial thymidine kinase 2 (TK2) sensitizes cancer cells to gemcitabine and increases mitochondrial toxicity
    Di Cresce, C.
    Ferguson, P.
    Figueredo, R.
    Rytelewski, M.
    Vareki, S. Maleki
    Vincent, M. D.
    Koropatnick, J.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 21 - 21
  • [50] Case Report: Thymidine Kinase 2 (TK2) Deficiency: A Novel Mutation Associated With Childhood-Onset Mitochondrial Myopathy and Atypical Progression
    Manini, Arianna
    Meneri, Megi
    Rodolico, Carmelo
    Corti, Stefania
    Toscano, Antonio
    Comi, Giacomo Pietro
    Musumeci, Olimpia
    Ronchi, Dario
    FRONTIERS IN NEUROLOGY, 2022, 13